Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Provention Bio
Provention Bio
(PRVB)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Tzield
Teplizumab
2022-11-17
Type 1 diabetes mellitus
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Teplizumab
diabetes mellitus
,
type 1 diabetes mellitus
Cilmostim
neoplasm metastasis
,
meningeal neoplasms
,
meningeal carcinomatosis
,
hodgkin disease
EDICOTINIB
non-hodgkin lymphoma
,
lymphoma
,
hodgkin disease
,
rheumatoid arthritis
,
arthritis
Globulin, immune
renal cell carcinoma
,
uterine cervical neoplasms
,
mesothelioma
,
hepatocellular carcinoma
,
esophageal squamous cell carcinoma
,
urologic neoplasms
,
liver neoplasms
,
basal cell carcinoma
,
anus neoplasms
,
transitional cell carcinoma
,
esophageal neoplasms
,
uveal neoplasms
,
uveal melanoma
,
digestive system neoplasms
,
ovarian epithelial carcinoma
,
hereditary breast and ovarian cancer syndrome
,
hereditary sensory and autonomic neuropathies
,
t-cell lymphoma peripheral
,
t-cell lymphoma cutaneous
,
neoplasms
,
breast neoplasms
,
melanoma
,
merkel cell carcinoma
,
carcinoma
,
small cell lung carcinoma
,
non-hodgkin lymphoma
,
b-cell chronic lymphocytic leukemia
,
pancreatic neoplasms
,
squamous cell carcinoma
,
myeloproliferative disorders
,
nasopharyngeal carcinoma
,
nasopharyngeal neoplasms
,
triple negative breast neoplasms
,
hodgkin disease
,
myelodysplastic syndromes
,
myeloid leukemia acute
,
hematologic neoplasms
,
primary myelofibrosis
,
glioblastoma
,
precursor cell lymphoblastic leukemia-lymphoma
,
endometrial neoplasms
,
stomach neoplasms
,
cholangiocarcinoma
,
ovarian neoplasms
,
leukemia
,
bcr-abl positive chronic myelogenous leukemia
,
myelomonocytic leukemia chronic
,
glioma
,
multiple myeloma
,
skin neoplasms
,
animal mammary neoplasms
,
pemphigus
,
burkitt lymphoma
,
philadelphia chromosome
,
epstein-barr virus infections
,
sarcoma
,
myelomonocytic leukemia acute
,
leukemia myeloid chronic atypical bcr-abl negative
,
myelodysplastic-myeloproliferative diseases
,
myelomonocytic leukemia juvenile
,
prolymphocytic leukemia
,
refractory anemia with excess of blasts
,
b-cell leukemia
,
thrombocytopenic purpura idiopathic
,
b-cell lymphoma
,
non-small-cell lung carcinoma
,
colorectal neoplasms
,
large b-cell lymphoma diffuse
,
squamous cell carcinoma of head and neck
,
graft vs host disease
,
follicular lymphoma
,
lymphoma
,
lung neoplasms
,
bronchiolitis obliterans syndrome
,
b-cell lymphoma marginal zone
,
recurrence
,
head and neck neoplasms
,
neoplasm metastasis
,
mantle-cell lymphoma
,
colonic neoplasms
,
rheumatoid arthritis
PRV-3279
healthy volunteers/patients
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use